Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lung.
about
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma.Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.Treatment options for patients with large cell neuroendocrine carcinoma of the lung.Treatment of lung large cell neuroendocrine carcinoma.Advances on systemic treatment for lung neuroendocrine neoplasms.
P2860
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lung.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@ast
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@en
type
label
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@ast
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@en
prefLabel
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@ast
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@en
P2093
P356
P1476
Amrubicin monotherapy for pati ...... docrine carcinoma of the lung.
@en
P2093
Hidehito Horinouchi
Hiroshi Nokihara
Hiroshi Yoshida
Ikuo Sekine
Kaoru Kubota
Koji Tsuta
Noboru Yamamoto
Tomohide Tamura
P304
P356
10.1093/JJCO/HYR065
P577
2011-06-02T00:00:00Z